{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T22:12:39Z","timestamp":1781907159941,"version":"3.54.5"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,3]]},"DOI":"10.7759\/cureus.59599","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T18:53:27Z","timestamp":1714762407000},"source":"Crossref","is-referenced-by-count":5,"title":["High Efficacy of Oral Tetracyclines in Prosthetic Joint Infection Treated With Debridement, Antibiotics, and Implant Retention (DAIR) or Resection Arthroplasty With Destination Spacer Placement"],"prefix":"10.7759","author":[{"given":"Timothy L","family":"Jang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Hewlett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas W","family":"Cortes-Penfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis803","article-title":"Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America","volume":"56","author":"Osmon DR","year":"2013","unstructured":"Osmon DR, Berbari EF, Berendt AR, et al.. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013, 56:e1-e25. 10.1093\/cid\/cis803","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2020198","article-title":"Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection","volume":"384","author":"Bernard L","year":"2021","unstructured":"Bernard L, Arvieux C, Brunschweiler B, et al.. Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection. N Engl J Med. 2021, 384:1991-2001. 10.1056\/NEJMoa2020198","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2018.08.016","article-title":"Two-stage revision Total Hip Arthroplasty with a specific articulating antibiotic spacer design: reliable periprosthetic joint infection eradication and functional improvement","volume":"33","author":"Chalmers BP","year":"2018","unstructured":"Chalmers BP, Mabry TM, Abdel MP, Berry DJ, Hanssen AD, Perry KI. Two-stage revision Total Hip Arthroplasty with a specific articulating antibiotic spacer design: reliable periprosthetic joint infection eradication and functional improvement. J Arthroplasty. 2018, 33:3746-53. 10.1016\/j.arth.2018.08.016","journal-title":"J Arthroplasty"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s42836-023-00167-6","article-title":"Articulating spacers: what are available and how to utilize them?","volume":"5","author":"Li Z","year":"2023","unstructured":"Li Z, Xu C, Chen J. Articulating spacers: what are available and how to utilize them?. Arthroplasty. 2023, 5:22. 10.1186\/s42836-023-00167-6","journal-title":"Arthroplasty"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/os.12996","article-title":"Destination joint spacers: a similar infection-relief rate but higher complication rate compared with two-stage revision","volume":"13","author":"Cai YQ","year":"2021","unstructured":"Cai YQ, Fang XY, Huang CY, et al.. Destination joint spacers: a similar infection-relief rate but higher complication rate compared with two-stage revision. Orthop Surg. 2021, 13:884-91. 10.1111\/os.12996","journal-title":"Orthop Surg"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz062","article-title":"Destination joint spacers, reinfection, and antimicrobial suppression","volume":"69","author":"Valencia JC","year":"2019","unstructured":"Valencia JC, Abdel MP, Virk A, Osmon DR, Razonable RR. Destination joint spacers, reinfection, and antimicrobial suppression. Clin Infect Dis. 2019, 69:1056-9. 10.1093\/cid\/ciz062","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad360","article-title":"Periprosthetic joint infection: Current clinical challenges include","volume":"77","author":"Nelson SB","year":"2023","unstructured":"Nelson SB, Pinkney JA, Chen AF, Tande AJ. Periprosthetic joint infection: Current clinical challenges include. Clin Infect Dis. 2023, 77:e34-45. 10.1093\/cid\/ciad360","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1710926","article-title":"Oral versus intravenous antibiotics for bone and joint infection","volume":"380","author":"Li HK","year":"2019","unstructured":"Li HK, Rombach I, Zambellas R, et al.. Oral versus intravenous antibiotics for bone and joint infection. N Engl J Med. 2019, 380:425-36. 10.1056\/NEJMoa1710926","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2022.106598","article-title":"Short- versus standard-course intravenous antibiotics for peri-prosthetic joint infections managed with debridement and implant retention: a randomised pilot trial using a desirability of outcome ranking (DOOR) endpoint","volume":"60","author":"Manning L","year":"2022","unstructured":"Manning L, Metcalf S, Dymock M, et al.. Short- versus standard-course intravenous antibiotics for peri-prosthetic joint infections managed with debridement and implant retention: a randomised pilot trial using a desirability of outcome ranking (DOOR) endpoint. Int J Antimicrob Agents. 2022, 60:106598. 10.1016\/j.ijantimicag.2022.106598","journal-title":"Int J Antimicrob Agents"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.11321","article-title":"Use of novel strategies to develop guidelines for management of pyogenic osteomyelitis in adults: a wikiguidelines group consensus statement","volume":"5","author":"Spellberg B","year":"2022","unstructured":"Spellberg B, Aggrey G, Brennan MB, et al.. Use of novel strategies to develop guidelines for management of pyogenic osteomyelitis in adults: a wikiguidelines group consensus statement. JAMA Netw Open. 2022, 5:e2211321. 10.1001\/jamanetworkopen.2022.11321","journal-title":"JAMA Netw Open"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2018.08.017","article-title":"Debridement, antibiotics and implant retention for periprosthetic joint infections: a systematic review and meta-analysis of treatment outcomes","volume":"77","author":"Kunutsor SK","year":"2018","unstructured":"Kunutsor SK, Beswick AD, Whitehouse MR, Wylde V, Blom AW. Debridement, antibiotics and implant retention for periprosthetic joint infections: a systematic review and meta-analysis of treatment outcomes. J Infect. 2018, 77:479-88. 10.1016\/j.jinf.2018.08.017","journal-title":"J Infect"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2203477","article-title":"Periprosthetic joint infection","volume":"388","author":"Patel R","year":"2023","unstructured":"Patel R. Periprosthetic joint infection. N Engl J Med. 2023, 388:251-62. 10.1056\/NEJMra2203477","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab426","article-title":"If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections, a multicentre observational study","volume":"73","author":"Beldman M","year":"2021","unstructured":"Beldman M, L\u00f6wik C, Soriano A, et al.. If, when, and how to use rifampin in acute staphylococcal periprosthetic joint infections, a multicentre observational study. Clin Infect Dis. 2021, 73:1634-41. 10.1093\/cid\/ciab426","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkaa061","article-title":"Antibiofilm and intraosteoblastic activities of rifamycins against Staphylococcus aureus: promising in vitro profile of rifabutin","volume":"75","author":"Abad L","year":"2020","unstructured":"Abad L, Josse J, Tasse J, et al.. Antibiofilm and intraosteoblastic activities of rifamycins against Staphylococcus aureus: promising in vitro profile of rifabutin. J Antimicrob Chemother. 2020, 75:1466-73. 10.1093\/jac\/dkaa061","journal-title":"J Antimicrob Chemother"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa401","article-title":"Novel use of rifabutin and rifapentine to treat Methicillin-resistant Staphylococcus aureus in a rat model of foreign body osteomyelitis","volume":"222","author":"Karau MJ","year":"2020","unstructured":"Karau MJ, Schmidt-Malan SM, Albano M, et al.. Novel use of rifabutin and rifapentine to treat Methicillin-resistant Staphylococcus aureus in a rat model of foreign body osteomyelitis. J Infect Dis. 2020, 222:1498-504. 10.1093\/infdis\/jiaa401","journal-title":"J Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics9060326","article-title":"Rifabutin use in Staphylococcus biofilm infections: a case series","volume":"9","author":"Doub JB","year":"2020","unstructured":"Doub JB, Heil EL, Ntem-Mensah A, Neeley R, Ching PR. Rifabutin use in Staphylococcus biofilm infections: a case series. Antibiotics (Basel). 2020, 9:326. 10.3390\/antibiotics9060326","journal-title":"Antibiotics (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/251430-high-efficacy-of-oral-tetracyclines-in-prosthetic-joint-infection-treated-with-debridement-antibiotics-and-implant-retention-dair-or-resection-arthroplasty-with-destination-spacer-placement","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T18:53:30Z","timestamp":1714762410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/251430-high-efficacy-of-oral-tetracyclines-in-prosthetic-joint-infection-treated-with-debridement-antibiotics-and-implant-retention-dair-or-resection-arthroplasty-with-destination-spacer-placement"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.59599","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,3]]}}}